Ontology highlight
ABSTRACT: Background
Successful gene therapy will require targeted delivery vectors capable of self-directed localization. In this regard, the use of antibodies or single chain antibody fragments (scFv) in conjunction with adenovirus (Ad) vectors remains an attractive means to achieve cell-specific targeting. However, a longstanding barrier to the development of Ad vectors with genetically incorporated scFvs has been the biosynthetic incompatibility between Ad capsid proteins and antibody-derived species. Specifically, scFv require posttranslational modifications not available to Ad capsid proteins due to their cytoplasmic routing during protein synthesis and virion assembly.Methodology/principal findings
We have therefore sought to develop scFv-targeted Ad vectors using a secreted s
SUBMITTER: Glasgow JN
PROVIDER: S-EPMC2791226 | biostudies-literature | 2009 Dec
REPOSITORIES: biostudies-literature